Cancer Genetics, Inc. (CGIX) is an early stage diagnostic company that focuses on the prognosis and response for treating cancer. There is more of a demand for companies like this than ever before and the technical charts tell us this stock is getting ready to break out. This is a contingent buy order, which means you will have to wait for the signal towards the end of the trading day before you buy it.
To gain access to the PDF download and video, sign up for
an Equity Oracle Subscription!
